Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Commentary

Low risk of depression in diabetes? Would that it were so

Deborah J. Wexler
CMAJ July 04, 2006 175 (1) 47; DOI: https://doi.org/10.1503/cmaj.060612
Deborah J. Wexler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Practitioners who care for patients with diabetes are familiar with the problems of comorbid depression: decreased compliance with treatment, increased risk of complications and disability, and diminished health-related quality of life. The large body of data outlined by Brown and colleagues1 has demonstrated that the prevalence of depression is increased in diabetes and vice-versa. How, then, are we to understand their finding1 that type 2 diabetes does not increase the risk of depression?

Using administrative databases that capture 99% of Saskatchewan's population, these authors identified 31 635 adults with type 2 diabetes newly diagnosed between 1992 and 2000, and followed them for an average of 4.5 years. Patients with type 2 diabetes were identified by outpatient or inpatient service codes for diabetes; gestational diabetes was excluded. The study cohort was limited to those dispensed a hypoglycemic drug to be taken orally; subjects who met the case definition within the preceding 3 years (1989 through 1991) were excluded. Controls were 57 141 people without diabetes who were randomly selected from the database and matched to cases only by the date of identification of diabetes.

Similarly, patients in the cohort who experienced depression were identified by the diagnosis codes for depressive disorders and prescriptions for antidepressant medications. Again, patients who met this definition during the 3 years preceding the study period were excluded. With this method, a greater proportion of cases (4.9% of patients with diabetes) than controls (3.8% of patients without diabetes) were excluded from the study cohort because of prior depression. In the remaining cohort, the authors modelled the hazard ratio of new-onset depression according to presence of diabetes both in crude models and in models adjusted for age, sex, number of physician visits, insulin usage and comorbidities (including arthritis, cancer, stroke, coronary artery disease and peripheral arterial disease).

With these selection criteria, the authors included subjects with generally recent-onset, mild type 2 diabetes, and excluded depression-prone subjects (i.e., those with a history of depression). Although type 2 diabetes can be quite advanced at the time of diagnosis, most patients with type 2 diabetes do not develop serious complications within 5 years of diagnosis. Moreover, by including only subjects treated with oral hypoglycemics, Brown's group excluded as well those patients with severe comorbidities (e.g., renal failure, heart failure) that preclude oral hypoglycemic use; such comorbidities are known to be associated with depression. As a result of their selection criteria, the authors have suggested that patients with relatively recent-onset diabetes, and with little in the way of advanced complications, are not at higher risk for depression than people without diabetes.

However, their data belie their title, since even patients with new-onset diabetes had an increased risk of depression; those with more severe diabetes had an even higher risk. In this study's Saskatchewan population, patients with diabetes had a statistically significant 10% increased risk of developing depression in crude analyses. Patients treated with insulin — which the authors appropriately consider to be a proxy for severity of disease — had an unadjusted 34% increase in their risk of developing depression. After adjusting for peripheral arterial disease (and thereby controlling for the effect of severe complications), diabetes alone was no longer associated with increased risk of depression, whereas complications of diabetes marked by the presence of peripheral arterial disease were.

Other studies have shown that mild, asymptomatic, type 2 diabetes is not associated with depression or impaired quality of life, whereas symptomatic comorbidities and insulin use appear to be risk factors.2–5 Population-based studies, as opposed to those carried out in clinical settings, have shown relatively high quality of life in patients with type 2 diabetes.6,7 Brown and colleagues' results are consistent with those of prior studies and suggest that although asymptomatic early diabetes may not increase the risk for depression, the risk of depression is increased when all patients with diabetes are taken into account.

The onset of type 2 diabetes is far more insidious than many other diseases such as stroke, which has an abrupt and devastating onset, or arthritis, which is usually diagnosed after pain has developed; both of these conditions are strongly associated with depression in this and other studies. In the absence of hyper-or hypoglycemia, patients with early type 2 diabetes may be asymptomatic. Once complications emerge, the prevalence and risk of depression climbs. Brown and colleagues' findings remind us that we should focus our attention among patients newly diagnosed with diabetes on prevention of complications, while at the same time remaining sensitive to the risk of depression if, despite all efforts, complications of diabetes develop.

@ See related article page 42

Footnotes

  • This article has been peer reviewed.

    Competing interests: None declared.

REFERENCES

  1. 1.↵
    Brown LC, Majumdar SR, Newman SC, et al. Type 2 diabetes does not increase risk of depression. CMAJ 2006;175(1):42-6.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Wexler DJ, Grant RW, Wittenberg E, et al. Correlates of health-related quality of life in type 2 diabetes. Diabetologia DOI: 10.1007/s00125-006-0249-9. Epub 2006 Apr 29 ahead of print.
  3. 3.
    UK Prospective Diabetes Study Group. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care 1999;22:1125-36.
    OpenUrlAbstract/FREE Full Text
  4. 4.
    Redekop WK, Koopmanschap MA, Stolk RP, et al. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care 2002;25:458-63.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    Bell RA, Smith SL, Arcury TA, et al. Prevalence and correlates of depressive symptoms among rural older African Americans, Native Americans, and whites with diabetes. Diabetes Care 2005;28:823-9.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    Manuel DG, Schultz SE. Health-related quality of life and health-adjusted life expectancy of people with diabetes in Ontario, Canada, 1996–1997. Diabetes Care 2004;27:407-14.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    Maddigan SL, Feeny DH, Johnson JA. Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey. Qual Life Res 2005;14:1311-20.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 175 (1)
CMAJ
Vol. 175, Issue 1
4 Jul 2006
  • Table of Contents
  • Index by author
  • Canadian Adverse Reaction Newsletter (p 109-116)

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Low risk of depression in diabetes? Would that it were so
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Low risk of depression in diabetes? Would that it were so
Deborah J. Wexler
CMAJ Jul 2006, 175 (1) 47; DOI: 10.1503/cmaj.060612

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Low risk of depression in diabetes? Would that it were so
Deborah J. Wexler
CMAJ Jul 2006, 175 (1) 47; DOI: 10.1503/cmaj.060612
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Responses
  • Metrics
  • PDF

Related Articles

  • Highlights of this issue
  • Dans ce numéro
  • Type 2 diabetes does not increase risk of depression
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Ensuring timely genetic diagnosis in adults
  • The case for improving the detection and treatment of obstructive sleep apnea following stroke
  • Laser devices for vaginal rejuvenation: effectiveness, regulation and marketing
Show more Commentary

Similar Articles

Collections

  • Topics
    • Diabetes
    • Psychiatry & mental health: adult

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

CMA Civility, Accessibility, Privacy

 

Powered by HighWire